PIP and neoplasm: In the present study, which aimed to determine the expression of GCDFP-15 in common grades of breast cancer, the expression of the GCDFP-15 marker (staining of more than 5% of tumor cells in immunohistochemistry) in 20 patients (33.3%) was observed.